Acetazolamide enhancement of HIPDM brain flow distribution imaging.
Six patients with symptomatic cerebral vascular disease were studied with 133Xe regional cerebral blood flow measurements and HIPDM cerebral imaging after the administration of acetazolamide. The results obtained from this small group suggest this technique may have high sensitivity for detection of cerebral vascular disease.
D000086:Acetazolamide; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging*; D006801:Humans; D007462:Iodobenzenes; D014055:Tomography, Emission-Computed / Q000379:methods; D014980:Xenon Radioisotopes
D007462:Iodobenzenes; D014980:Xenon Radioisotopes; C036739:N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine; D000086:Acetazolamide